| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.43B | -27.7% |
| Cost of Revenue | $787.8M | -31.7% |
| Gross Profit | $642.8M | -22.3% |
| R&D Expense | $90.7M | -21.6% |
| SG&A Expense | $761.3M | +34.3% |
| Operating Income | -$348.2M | -486.0% |
| Pre-tax Income | -$481.3M | -178.3% |
| Income Tax | -$23.8M | -117.3% |
| Net Income | -$489.5M | -202.4% |
| EPS (Basic) | -$17.50 | -172.1% |
| EPS (Diluted) | -$17.50 | -172.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $812.8M | +112.4% |
| Accounts Receivable | $299.1M | -24.3% |
| Inventory | $553.5M | -16.8% |
| Current Assets | $1.92B | +17.9% |
| Total Assets | $5.63B | +70.4% |
| Current Liabilities | $672.1M | +55.8% |
| Long-term Debt | $2.53B | +178.4% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $50.4M | -55.5% |
| $3.56B |
| +115.1% |
| Stockholders' Equity | $2.07B | +25.5% |